In line with the above findings, our analysis of publicly available expression datasets of cancer (TCGA) and normal tissues (GTEx) revealed that the level of NANOS2 diminished in testis cancer compared to normal testis tissues (Figure 3A). The gene discussed is NANOS2; the disease is testicular cancer.